OTCMKTS:SPZR Enveric Biosciences (SPZR) Stock Price, News & Analysis → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free SPZR Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume12,294 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Enveric Biosciences alerts: Email Address Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy About Enveric Biosciences Stock (OTCMKTS:SPZR)Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments. The firm is testing natural compounds, starting with cannabinoids to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs. The company is headquartered in Naples, FL.Read More Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy SPZR Stock News HeadlinesApril 18, 2024 | msn.comEnveric Biosciences (ENVB) Price Target Decreased by 11.11% to 8.16March 19, 2024 | marketwatch.comEnveric Biosciences Shares Pop 20% After Out-Licensing Deals Valued Up to $82MApril 28, 2024 | Prosper Trading Academy (Ad)These AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet.February 29, 2024 | msn.comWhy Enveric Biosciences Stock Is SoaringFebruary 29, 2024 | msn.comEXCLUSIVE: Enveric Biosciences Announces Non-Binding Deals To License Out Three Types of Drug CompoundsFebruary 25, 2024 | msn.comEnveric Biosciences (ENVB) Price Target Increased by 5.88% to 9.18February 23, 2024 | msn.comEnveric Biosciences Sells Cancer Patents As It Paves Way For Mental Health TreatmentsFebruary 23, 2024 | marketwatch.comEnveric Biosciences to Sell Cannabinoid-Related IPApril 28, 2024 | Prosper Trading Academy (Ad)These AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet.February 13, 2024 | wsj.comPacira BioSciences Inc.January 30, 2024 | realmoney.thestreet.comEnveric Biosciences initiated with bullish view at H.C. Wainwright, here's whyJanuary 11, 2024 | msn.comEnveric Biosciences files to sell 2.24M shares for holdersNovember 14, 2023 | benzinga.comEnveric Biosciences' Revenue Drops In Q3 2023 As Next-Gen Psychedelics Advance To Clinical TrialsNovember 8, 2023 | msn.comEnveric Biosciences files to sell 1.2M shares for holdersAugust 28, 2023 | benzinga.comBoosting Next-Gen Mental Health Care: Enveric's New US Patent For Anxiety TreatmentJuly 17, 2023 | markets.businessinsider.comEnveric Biosciences Reports Positive Results From Animal Studies With EB-373May 18, 2023 | msn.comWhy Is Enveric Biosciences (ENVB) Stock Up 120% Today?May 18, 2023 | marketwatch.comEnveric Biosciences Shares Rise 40% After Notice of Allowance for Psilocin U.S. PatentMay 18, 2023 | msn.comEnveric Biosciences Receives Notice Of Allowance From US Patent And Trademark Office For Novel Prodrug Of PsilocinMay 18, 2023 | msn.comEnveric soars ~130% on upcoming US patent linked to psilocin prodrug EB-373 for anxietyMay 15, 2023 | markets.businessinsider.comEnveric Biosciences Plans About 35 Percent Reduction In Full-time PersonnelMay 15, 2023 | benzinga.comEnveric Biosciences Reports First Quarter 2023 Financial Results and Operational HighlightsApril 20, 2023 | msn.comEXCLUSIVE: Fireside With Enveric Biosciences's Dr. Tucker, Unlocking Psychedelic Healing BenefitsApril 3, 2023 | seekingalpha.comEnveric Biosciences GAAP EPS of -$13.00 misses by $0.54March 1, 2023 | msn.comEnveric Biosciences gets new finance chiefJuly 27, 2022 | apnews.comEnveric Biosciences Appoints New Independent DirectorsMay 11, 2022 | seekingalpha.comEnveric to spin out cannabinoid pipeline into a public companySee More Headlines Receive SPZR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Enveric Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorComputer and Technology Industry Data Processing Services Sub-IndustryN/A Current SymbolOTCMKTS:SPZR CUSIPN/A CIK890821 Webwww.ameri100.com Phone(239) 302-1707FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesJoseph TuckerChief Executive Officer & DirectorAvani V. KanubaddiPresident & Chief Operating OfficerKevin M CoveneyChief Financial OfficerJillian HagelChief Technology OfficerBob DagherChief Medical OfficerKey Competitors(UPGI)OTCMKTS:UPGI01 Communique LaboratoryOTCMKTS:OCQLF12 ReTechOTCMKTS:RETC1mage SoftwareOTCMKTS:ISOL24SevenOffice Group AB (publ)OTCMKTS:TFSVFView All Competitors SPZR Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Enveric Biosciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Enveric Biosciences investors own include BOX (BOX) and Coty (COTY). How do I buy shares of Enveric Biosciences? Shares of SPZR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:SPZR) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enveric Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
